周末观察
活细胞生物墨水打印半月板:犬模型有再生线索
本栏当日无常规新论文批次;仅整理最新可见的 2026-07-24 原始记录,未把观察日写成发表日。 检索覆盖 bioprinting、3D bioprinting、biofabrication、bioink、bioprinted tissue、in situ bioprinting及与组织工程、再生医学或活细胞明确相连的additive manufacturing;排除惰性植入物、牙科、导板和教学模型。
研究使用半月板去细胞外基质生物墨水、间充质干细胞和聚合物复合材料打印各向异性构建体;犬模型植入12和24周出现软骨保护和新半月板形成线索。
这是体外与犬模型证据,不是人体临床疗效;纳入依据是活细胞、生物墨水与组织工程目标。
社区脉动 · 已验证公开来源
社交网络雷达
2026-07-26—2026-07-26. 以下条目来自公开 API,并已核验原帖链接与北京时间窗口。它们反映公开关注和讨论,不代表论文质量、临床效力或学术共识。
RRID Robot @rridrobot.bsky.social
Immune-Responsive Bioinks Enable Vision-Guided in Situ Robotic Bioprinting to Accelerate Diabetic Wound Healing
RRIDs were included in this in Advanced Functional Materials paper. RRIDs improve reproducibility in scientific research. #accelerateopenscience #methodsmatter #reproducibility
Safety In Numbers @safetyinnumbers.bsky.social
Japan Clears First iPSC Therapies for Clinical Use
Just this year, Japan conditionally approved a special iPSC therapy to regrow the heart after major heart attack, and treatment for Parkinson's. themedicinemaker.com/issues/2026/... In contrast, bioprinting organs is still a ways off, alas.